Table S1.
HUGO approved name | Symbol | Other |
---|---|---|
V-akt murine thymoma viral oncogene homolog 3 | AKT3 | |
Anaplastic lymphoma receptor tyrosine kinase | ALK | |
AT rich interactive domain 1A (SWI-like) | ARID1A | |
ATM serine/threonine kinase | ATM | |
BCL2-like 1 | BCL2L1 | BCLXL |
BCL2-like 11 (apoptosis facilitator) | BCL2L11 | BIM |
B-Raf proto-oncogene, serine/threonine kinase | BRAF | |
Coiled–coil domain containing 6 | CCDC6 | |
Cyclin-dependent kinase inhibitor 2A | CDKN2A | |
Checkpoint kinase 1 | CHEK1 | |
Checkpoint kinase 2 | CHEK2 | |
Cytotoxic T-lymphocyte-associated protein 4 | CTLA4 | |
Deoxythymidylate kinase (thymidylate kinase) | DTYMK | |
Epidermal growth factor receptor | EGFR | ERBB1 |
Echinoderm microtubule associated protein like 4 | EML4 | |
V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | ERBB2 | HER2 |
Mitogen-activated protein kinase 3 | MAPK3 | ERK1 |
Mitogen-activated protein kinase 1 | MAPK1 | ERK2 |
Fibroblast growth factor receptor 1 | FGFR1 | |
Hepatocyte growth factor | HGF | |
Major histocompatibility complex, class I, A | HLA-A | |
Harvey rat sarcoma viral oncogene homolog | HRAS | |
Heat shock protein 90kDa alpha (cytosolic), class A member 1 | HSP90AA1 | |
Insulin-like growth factor 1 receptor | IGFR1 | |
Kelch-like ECH-associated protein 1 | KEAP1 | |
Kinesin family member 5B | KIF5B | |
Kirsten rat sarcoma viral oncogene homolog | KRAS | |
Mitogen-activated protein kinase kinase 1-7 | MAP2K1-7 | MEK |
MET proto-oncogene, receptor tyrosine kinase | MET | HGFR |
Lysine (K)-specific methyltransferase 2D | KMT2D | |
Nuclear receptor coactivator 4 | NCOA4 | |
Neurofibromin 1 | NF1 | |
Nuclear factor, erythroid 2-like 2 | NFE2L2 | |
Notch 1 | NOTCH1 | |
Neuroblastoma RAS viral (v-ras) oncogene homolog | NRAS | |
Programmed cell death 1 | PDCD-1 | |
Platelet-derived growth factor receptor, beta polypeptide | PDGFRB | |
CD274 molecule | CD274 | PD-L1 |
Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | PIK3CA | |
Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta/delta | PIK3CB/D | |
Phosphoinositide-3-kinase, regulatory subunit 1-3 | PIK2R1-3 | |
Polo-like kinase 1 | PLK1 | |
Phosphatase and tensin homolog | PTEN | |
Retinoblastoma 1 | RB1 | |
RNA binding motif protein 10 | RBM10 | |
Ret proto-oncogene | RET | |
Ras-like without CAAX 1 | RIT1 | |
ROS proto-oncogene 1, receptor tyrosine kinase | ROS1 | |
SET domain containing 2 | SETD2 | |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | SMARCA4 | |
Serine/threonine kinase 11 | STK11 | LKB1 |
TRK-fused gene | TFG | |
Tumor protein p53 | TP53 | P53 |
Tripartite motif containing 33 | TRIM33 | |
U2 small nuclear RNA auxiliary factor 1 | U2AF1 | |
Vascular endothelial growth factor A | VEGFA | |
C-fos induced growth factor (vascular endothelial growth factor D) | FIGF | |
Kinase insert domain receptor (a type III receptor tyrosine kinase) | KDR | |
WEE1 G2 checkpoint kinase | WEE1 |
Abbreviation: HUGO, Human Genome Organisation.